AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Why Is Novo Nordisk Stock Entering Oversold Territory?
October 08, 2024 08:05 AM AEDT| By Team Kalkine MediaHighlights:,Novo Nordisk shares have declined approximately 17% in the past three months, nearing a 52-week low.,The stock is currently in oversold territory, with a Relative Strength Index (RSI) of 29.,Despite the sell-off, the company continues to...
Theralase Advances Bladder Cancer Study with Ruvidar
October 08, 2024 06:44 AM AEDT| By Team Kalkine MediaHighlights,Theralase's light-activated drug Ruvidar, used with the TLC-3200 laser system, is showing strong results in treating bladder cancer, with patient responses exceeding international benchmarks.,The Phase 2 clinical trial is focused on provid...
Theralase Updates on Bladder Cancer Treatment Progress
October 08, 2024 02:59 AM AEDT| By Team Kalkine MediaHighlights,Theralase Technologies reports a significant achievement with Ruvidar in its ongoing bladder cancer clinical study, surpassing benchmarks for complete response rates.,The study indicates promising long-term efficacy in bladder cancer treat...
Oncolytics Biotech® Inc. Provides Exciting Corporate Update for 2025
October 07, 2024 02:22 PM AEDT| By Team Kalkine MediaHighlights:,Positive BRACELET-1 Results: Oncolytics Biotech's recent clinical data demonstrates strong efficacy signals for pelareorep in breast cancer treatment.,Pancreatic Cancer Focus: The company is prioritizing pancreatic cancer research, aided...
Lifecore Biomedical Secures Funding for Expansion
October 05, 2024 10:03 AM AEST| By Team Kalkine MediaHighlights,Lifecore Biomedical completes a significant private placement, reinforcing confidence in its strategic direction and operational growth.,The capital raised will support ongoing operations and expand Lifecore's capabilities within the pharm...
DRI Healthcare Trust Acquires Payment Rights for CASGEVY® Gene-Editing Technology
October 04, 2024 10:00 PM AEST| By Team Kalkine MediaHighlights,DRI Healthcare Trust invests $57 million in Editas Medicine's payment rights linked to Vertex's CASGEVY® gene-editing therapy.,CASGEVY® is the first FDA-approved treatment using CRISPR technology for sickle cell disease and transfusion-dep...
PharmAla Biotech Partners with Harvard for MDMA Research
October 04, 2024 09:02 AM AEST| By Team Kalkine MediaHighlights,PharmAla Biotech has been contracted to supply MDMA for a clinical trial at Harvard’s prestigious McLean Hospital, further solidifying its role in advanced medical research.,The company is enhancing its U.S. supply chain by exploring ways...
Why Is CareRx’s Debt Management Strategy Gaining Attention?
October 04, 2024 04:55 AM AEST| By Team Kalkine MediaHighlights:,CareRx Corporation operates in the healthcare sector, providing pharmacy services to retirement and assisted living homes.,The company holds debt on its balance sheet, raising questions about its impact on financial stability.,Monitoring...
How Will Calian Group and Walmart Canada Transform Pharmacy Services?
October 02, 2024 06:59 AM AEST| By Team Kalkine MediaHighlights:,Strategic Partnership:,Calian Group Ltd. collaborates with Walmart Canada to enhance pharmacy services using the Nexi™ digital platform.,Digital Health Innovation:,Nexi™ offers modern solutions to streamline pharmacy operations and improv...
How Is AI Transforming the Future of Healthcare?
October 02, 2024 06:48 AM AEST| By Team Kalkine MediaHighlights,Generative AI is moving from hype to real-world applications, including healthcare.,Healthcare's complex structure has historically slowed technological adoption, but AI offers solutions to longstanding inefficiencies.,AI could unlock new...
Satellos Bioscience to Present Duchenne Data
October 02, 2024 06:27 AM AEST| By Team Kalkine MediaHighlights,Satellos Bioscience Inc. shares rise following data presentation announcement.,The company is set to present findings on SAT-3247 in a canine model of Duchenne muscular dystrophy.,The data will be showcased at the 29th Annual Congress of t...
What Makes This Hidden Canadian Opportunity Stand Out in 2024?
October 02, 2024 01:59 AM AEST| By Team Kalkine MediaHighlights,Significant earnings growth of 3957.1%, well above industry standards.,A diversified revenue stream across long-term care, home health care, and managed services.,Lower valuation compared to the Canadian market, with a P/E ratio of 13.3x.,...
Titan Medical to Transition from TSX to TSXV
October 01, 2024 09:50 AM AEST| By Team Kalkine MediaHighlights,Titan Medical announces plans to delist from the Toronto Stock Exchange and transition to the TSX Venture Exchange, aiming for a more suitable trading platform.,The move is part of a reverse takeover through the acquisition of Conavi Medic...
Which Canadian Tech Firm Is Revolutionizing the Market ?
October 01, 2024 03:46 AM AEST| By Team Kalkine MediaHighlights:,Revenue Growth,: Vitalhub’s year-over-year revenue increased by 24%, reaching CAD 16.24 million, significantly outpacing the Canadian market.,R&D Investments,: The company’s focus on research and development supports its competitive edge...
What Does Royal Bank of Canada’s Rating Mean for Phreesia’s Future?
September 28, 2024 07:16 AM AEST| By Team Kalkine MediaHighlights:,RBC Reaffirms Rating,: Royal Bank of Canada reaffirmed its "sector perform" rating for Phreesia, reflecting consistency in performance.,Stock Maintains Stability,: RBC's price target suggests the stock continues to show stability within t...
Why Are Pharma Giants Shifting Focus to Smaller Biotech Deals?
September 28, 2024 07:08 AM AEST| By Team Kalkine MediaKey Highlights:,Reduced M&A Activity,: 2024 saw a significant drop in biotech M&A, with total deal value falling to $26 billion from $42 billion in 2023.,Shift to Smaller Acquisitions,: A growing focus on smaller acquisitions and private biotech firm...
What Factors Contribute to Vibe Growth Corporation's Rising Share Price Despite Flat Revenues?
September 28, 2024 04:28 AM AEST| By Team Kalkine MediaHighlights,Recent Stock Performance,: Vibe Growth Corporation’s shares gained 31% in the last month but are still down 43% over the past year, indicating a mixed performance in the market.,Valuation Metrics,: The company’s price-to-sales ratio is not...
Aja Health and Wellness Begins Trading on TSX Venture Exchange Following Major Transaction
September 27, 2024 04:39 PM AEST| By Team Kalkine MediaAja Health and Wellness Inc. (formerly Premier Diversified Holdings Inc.) has officially commenced trading on the TSX Venture Exchange (TSX-V) under the symbol “AJA.” This follows the successful completion of a significant transaction involving AJA H...
Why Healwell AI (TSX:AIDX) Shares Have Gained 80% YTD?
September 27, 2024 04:36 PM AEST| By Team Kalkine MediaHealwell AI (TSX:AIDX), a healthcare technology company listed on the Toronto Stock Exchange under the symbol AIDX, has seen a dramatic 80% increase in its share price year-to-date. Trading at just $1.35 per share, Healwell has delivered a one-year r...
Key Approval Achieved for Titan Medical and Conavi Amalgamation
September 27, 2024 08:59 AM AEST| By Team Kalkine MediaHighlights,Titan Medical has received shareholder approval from Conavi Medical for a reverse takeover, marking a significant milestone for both companies in the healthcare sector.,The unanimous vote reflects strong confidence among Conavi shareholder...
Canadian AI All-Stars: Unveiling the Top Stocks for 2025